Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone 4H11] (IgG1,k) to Human FOLH1 / PSMA
Human FOLH1 / PSMA
Human (tested or 100% immunogen sequence identity)
IgG1,k Monoclonal [4H11]
Protein G purified
Specificity and Use
FOLH1 / PSMA antibody was raised against crude membrane protein extraction from PSMA expression LNCap cells, and a PSMA derived peptide (ESKVDPSKA) (KLH).
Recognizes human PSMA expression LNCap cells and the PSMA peptide. Reacts with human prostatic carcinoma tissue, but not with normal prostatic tissue by Immunohistochemistry. Little or no cross-reactivity to KLH and BSA.
Suitable for use in ELISA and Immunohistochemistry.
Lyophilized from PBS, pH 7.0
500 µl Sterile ddH2O
Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstituted product is stable for 12 months at -20°C Aliquot and store at -20°C.
FOLH1 / PSMA is a type II transmembrane glycoprotein belonging to the M28 peptidase family. The protein acts as a glutamate carboxypeptidase on different alternative substrates, including the nutrient folate and the neuropeptide N-acetyl-l-aspartyl-l-glutamate and is expressed in a number of tissues such as prostate, central and peripheral nervous system and kidney.